Benralizumab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Benralizumab
Treatment and conditionWhere it standsTrials
Benralizumab for hypereosinophilic syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Benralizumab for pulmonary disease, chronic obstructivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1